A neurosurgeon's view: Laser interstitial thermal therapy of mesial temporal lobe structures
A neurosurgeon's view: Laser interstitial thermal therapy of mesial temporal lobe structures
复制标题
DOI:
10.1016/j.eplepsyres.2017.10.015
复制
发表时间:
2018-05-01
影响因子:
2.2
通讯作者:
Gross, Robert E.
中科院分区:
文献类型:
--
作者:
Bezchlibnyk, Yarema B.;Willie, Jon T.;Gross, Robert E.
Stereotactic laser ablation of mesial temporal structures is a promising new surgical intervention for patients with mesial temporal lobe epilepsy (MTLE). Since this procedure was first used to treat MILE in 2010, the literature contains reports of 37 patients that underwent MR-guided stereotactic laser amygdalohippocampotomy (SLAH) using Laser Interstitial Thermal Therapy (LITT) with at least 1 year of follow-up. This early body of data suggests that SLAH is a safe and effective treatment for MILE in properly selected patients. Moreover, SLAH is substantially less invasive when compared with open surgical procedures including standard anterior temporal lobectomy and its more selective variants, results in immediate destruction of tissue in contrast to radiosurgical treatments for MTLE, and can more readily ablate larger volumes of tissue than is possible with techniques employing radiofrequency ablation. Finally, evidence is accruing that SLAH is associated with lower overall risk of neuropsychological deficits compared to open surgery. Thus, LITT constitutes a novel minimally invasive tool in the neurosurgeon's armamentarium for managing medically refractory seizures that may draw eligible patients to consider surgical interventions to manage their seizures.